Journal Basic Info
- Impact Factor: 0.285**
- H-Index: 6
- ISSN: 2638-4558
- DOI: 10.25107/2638-4558
Major Scope
- Pulmonary Medicine
- Sleep Medicine and Disorders
- Diabetology
- Molecular Biology
- Pneumonia
- Emergency Medicine and Critical Care
- Internal Medicine
- Forensic and Legal Medicine
Abstract
Citation: Clin Case Rep Int. 2022;6(1):1356.DOI: 10.25107/2638-4558.1356
Superior Vena Cava Obstruction with Thrombolytic Therapy in Primary Antiphospholipid Syndrome
Manal Adel, Kareem Mahmoud, Haithem Soliman, Shady Mashoor and Marwa Mashaal
Department of Cardiovascular, Kasraliany Medical School, Egypt
*Correspondance to: Manal Adel
PDF Full Text Case Report | Open Access
Abstract:
We report a case of superior vena cava obstruction of a 39 years old female patient with primary antiphospholipid syndrome presented with upper limb pain and swelling, which improved on thrombolytic therapy, we review patients with Antiphospholipid syndrome and management with thrombolytic therapy.
Keywords:
Superior Vena Cava (SVC); Antiphospholipid Syndrome (APS); MVC
Cite the Article:
Adel M, Mahmoud K, Soliman H, Mashoor S, Mashaal M. Superior Vena Cava Obstruction with Thrombolytic Therapy in Primary Antiphospholipid Syndrome. Clin Case Rep Int. 2022; 6: 1356.